WT集團(08422.HK)更改上市集資所得用途
WT集團(08422.HK)公布,2017年底在GEM上市,集資淨額約3,170萬元;屆上日(2019年7月23日)止,已動用所得款項淨額其中約2,090萬元,未動用所得款項淨額約1,080萬元。
由於股份已上市超過一年及經考慮集團業務策略及業務環境變遷,為更有效利用所得款項淨額及為促使有效分配公司財務資源,董事會已檢討所得款項淨額動用情況,並決議重新分配部分未動用所得款項淨額。
原先計劃撥付項目A及項目B履約保證需求之銀行結餘約570萬元已重新分配,以撥付於2019年獲授之若干項目,以及集團計劃爭取之其他潛在新項目初期之前期成本及營運資金需求。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.